Search results
Ipsen to Pay Marengo Therapeutics Up to $1.2 Billion Under Expanded Cancer Research Partnership
The Wall Street Journal· 7 days agoFrench pharmaceutical company Ipsen is expanding its oncology research partnership with Marengo...
Petri Dish: Ipsen’s drug approval; Discovery expands local footprint - Boston Business Journal
The Business Journals· 15 hours agoDrug approvals were at the center of two stories this week in the Petri Dish, as we dive into a...
Ipsen drug for rare liver disease approved by FDA
BioPharma Dive via Yahoo Finance· 2 days agoThe medicine will join Intercept’s Ocaliva as a treatment option for primary biliary cholangitis. Another drug, from the now Gilead-owned CymaBay, could...
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
Reuters via AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers ...
Ipsen gets hot on cold tumors, inking $1.2B biobucks deal for Marengo's T-cell engagers
FierceBiotech· 6 days agoIpsen is hot on Marengo Therapeutics’ ability to treat “cold” tumors. The French drugmaker has...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoIpsen (Euronext: IPN; ADR: IPSEY) and Marengo Therapeutics Inc, a clinical-stage biotech company, announced today the expansion of their ongoing oncology research partnership ...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoPublished exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0829 ET – Ipsen’s launch of its rare liver-disease drug in the coming...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 7 days agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
Significant Benefit With Liver Transplantation in ACLF
Medscape· 19 hours agoLiver transplantation improves survival in patients with acute-on-chronic liver failure (ACLF),...
Tacalyx extends seed funding round to raise over €14m
Pharmaceutical Technology via Yahoo Finance· 1 day agoIn related news in the T cell therapeutics space, French biopharmaceutical company Ipsen recently...
